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Abstract To detect the posttranslational N-myristoylation of
caspase substrates, the susceptibility of the newly exposed
N-terminus of known caspase substrates to protein N-myristoy-
lation was evaluated by in vivo metabolic labeling with
[3H]myristic acid in transfected cells using a fusion protein in
which the query sequence was fused to a model protein. As a
result, it was found that the N-terminal nine residues of the
newly exposed N-terminus of the caspase-cleavage product of
cytoskeletal actin e⁄ciently direct the protein N-myristoylation.
Metabolic labeling of COS-1 cells transiently transfected with
cDNA coding for full-length truncated actin (tActin) revealed
the e⁄cient incorporation of [3H]myristic acid into this mole-
cule. When COS-1 cells transiently transfected with cDNA cod-
ing for full-length actin were treated with staurosporine, an
apoptosis-inducing agent, an N-myristoylated tActin was gener-
ated. Immuno£uorescence staining coupled with MitoTracker or
£uorescence tagged-phalloidin staining revealed that exoge-
nously expressed tActin colocalized with mitochondria without
a¡ecting cellular and actin morphology. Taken together, these
results demonstrate that the C-terminal 15 kDa fragment of
cytoskeletal actin is posttranslationally N-myristoylated upon
caspase-mediated cleavage during apoptosis and targeted to mi-
tochondria.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
A number of eukaryotic cellular proteins are found to be
covalently modi¢ed with the 14-carbon saturated fatty acid,
myristic acid [1^6]. Many of the myristoylated proteins play
key roles in regulating cellular structure and function. They
include proteins involved in a wide variety of cellular signal
transduction pathways. In general, protein N-myristoylation is
the result of cotranslational addition of myristic acid to a Gly
residue at the extreme N-terminus after removal of the initiat-
ing Met by cellular methionylaminopeptidases. A stable amide
bond links myristic acid irreversibly to proteins. Recently, it
was demonstrated that protein N-myristoylation can also oc-
cur posttranslationally, as in the case of the pro-apoptotic
protein BID where proteolytic cleavage by caspase 8 reveals
a ‘hidden’ myristoylation motif [7]. The posttranslational
N-myristoylation of BID was demonstrated to be catalyzed
by N-myristoyltransferase (NMT), the enzyme responsible
for cotranslational N-myristoylation. It was also revealed
that N-myristoylation has a strong in£uence on BID targeting
to mitochondria, its insertion into the outer membrane of
mitochondria, the release of cytochrome c, and the killing of
cells. Thus, posttranslational N-myristoylation plays a critical
role in the biological activity of BID. Since about one-fourth
(16 of V60) of the identi¢ed caspase substrates expose an
N-terminal Gly upon cleavage [8], it was suggested that this
modi¢cation might be a common posttranslational modi¢ca-
tion in the apoptosis pathway [7]. However, so far, BID is the
only protein that has been proved experimentally to be post-
translationally N-myristoylated upon cleavage by caspase.
One possible reason for this might be the lack of a convenient
method to detect this unusual modi¢cation. In a previous
study, we have shown that the susceptibility of a protein to
cotranslational N-myristoylation could easily be detected by
metabolic labeling in an in vitro or in vivo expression system
using a fusion protein in which the N-terminal sequence (V10
amino acid residues) of the query protein was fused to a
model protein [9]. In the present study, we utilized this strat-
egy to detect posttranslational N-myristoylation of caspase
substrates. In this case, the initiating Met was inserted at
the N-terminus of the newly exposed N-terminus of the cas-
pase-cleavage products and the susceptibility of the N-termi-
nal sequence to protein N-myristoylation was evaluated by the
same methods as described above. As a result, it was found
that the N-terminal nine residues of the newly exposed N-ter-
minus of the caspase-cleavage products of cytoskeletal actin
and gelsolin e⁄ciently direct the protein N-myristoylation. In
fact, when COS-1 cells transiently transfected with cDNA
coding for epitope-tagged actin were treated with staurospo-
rine, an apoptosis-inducing agent, an N-myristoylated trun-
cated actin (tActin) was generated as demonstrated by in
vivo metabolic labeling with [3H]myristic acid. Immuno£uo-
rescence staining coupled with MitoTracker or £uorescence
tagged-phalloidin staining revealed that exogenously ex-
pressed tActin colocalized with mitochondria without a¡ect-
ing cellular and actin morphology. These results clearly dem-
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onstrated that the C-terminal 15 kDa fragment of cytoskeletal
actin is posttranslationally N-myristoylated upon caspase-
mediated cleavage during apoptosis and targeted to mitochon-
dria. Thus, the metabolic labeling of a fusion protein having a
newly exposed N-terminus is a useful strategy to detect post-
translational N-myristoylation of cellular proteins. This is the
¢rst report, to our knowledge, showing that posttranslational
N-myristoylation occurred on other caspase substrates as well
as on a pro-apoptotic protein BID.
2. Materials and methods
2.1. Materials
Restriction endonucleases, DNA-modifying enzymes, RNase inhib-
itor, and Taq DNA polymerase were purchased from Takara Shuzo,
Kyoto, Japan. RNase was obtained from Boehringer-Mannheim, Ger-
many. [3H]leucine, [3H]myristic acid, and Amplify were from Amer-
sham, UK. The Dye Terminator Cycle Sequencing kit was from Ap-
plied Biosystems, USA. Anti-human tumor necrosis factor (TNF)
polyclonal antibody was purchased from RpD systems, USA. Anti-
FLAG monoclonal antibody and TRITC-conjugated phalloidin were
purchased from Sigma, USA. MitoTracker red CM-H2XRos was ob-
tained from Molecular Probes, The Netherlands. Protein G Sepharose
was from Pharmacia Biotech, Sweden. Plasmid pEYFP-Actin was
obtained from Clontech, USA. Other reagents purchased from
Wako Pure Chemical, Daiichi Pure Chemicals, and Seikagaku Kogyo
(Japan) were of analytical or DNA grade.
2.2. Plasmid construction
Plasmid pBluescript II SK(+) lacking ApaI and HinDIII sites was
constructed as previously described [10], and designated pB. Plasmid
pBvpro-TNF, which contains a cDNA coding for the mature domain
of TNF, was constructed as described in [11,12]. Plasmid pBtBID-
TNF was constructed by utilizing polymerase chain reaction (PCR).
For this procedure, pBvpro-TNF served as a template and two oli-
gonucleotides (tBID, B1) served as primers (Table 1). After digestion
with BamHI and PstI, the ampli¢ed product was subcloned into pB at
BamHI and PstI sites. Plasmids pBtPARP-, pBtPKCj-, pBtp59FYN-,
pBtActin-, pBtGelsolin- and pBtMEKK-1-TNF were constructed by
a method similar to that of pBtBID-TNF using two oligonucleotides
(tPARP plus B1, tPKCj plus B1, tp59FYN plus B1, tActin plus B1,
tGelsolin plus B1 and tMEKK-1 plus B1, respectively) as primers
(Table 1). Plasmid pB-FLAG, which contains the sequence for the
FLAG epitope at the C-terminus, was constructed as follows. The
EcoRI/ApaI fragment coding for FLAG epitope was excised from
PCMV-Tag4 vector (Stratagene) and then subcloned into pBluescript
II SK(+) at EcoRI and ApaI sites. Plasmid pBtActin-FLAG, which
contains a cDNA coding for FLAG-tagged tActin, was constructed
by utilizing PCR. For this procedure, pEYFP-Actin (Clontech) served
as a template and two oligonucleotides (N-ACT15, C-ACT) as prim-
ers (Table 1). After digestion with BamHI and EcoRI, the ampli¢ed
product was subcloned into pB-FLAG at BamHI and EcoRI sites.
Plasmid pBtActinG2A-FLAG was constructed by a method similar
to that of pBtActin-FLAG using two oligonucleotides (tACTG2A,
C-ACT) as primers (Table 1). Plasmid pBActin-FLAG, which con-
tains a cDNA coding for FLAG-tagged full-length actin, was con-
structed by a method similar to that of pBtActin-FLAG using two
oligonucleotides (N-ACT, C-ACT) as primers (Table 1). The DNA
sequences of these recombinant cDNAs were con¢rmed by the di-
deoxy-nucleotide chain termination method [13]. The cDNAs coding
for TNF mutants and actin mutants were subcloned into pcDNA3
and the obtained pcDNA3 constructs were used for transfection as-
say.
2.3. Transfection of COS-1 cells and determination of N-myristoylated
proteins
The simian virus 40-transformed African Green monkey kidney cell
line, COS-1, was maintained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM; Gibco BRL) supplemented with 10% fetal calf serum (FCS;
Gibco BRL). Cells (2U105) were plated onto 35 mm diameter dishes
1 day before transfection. pcDNA3 construct (2 Wg; Invitrogen, San
Diego, CA, USA) containing cDNA coding for mutant TNF or actin
was used to transfect each plate of COS-1 cells along with 4 Wl of
LipofectAmine (2 mg/ml; Gibco BRL) in 1 ml of serum-free medium.
After incubation for 5 h at 37‡C, the cells were refed with serum-
containing medium and incubated again at 37‡C for 48 h. The cells
were then washed twice with 1 ml of serum-free DMEM and incuba-
ted for 5 h at 37‡C in 1 ml of DMEM with 2% FCS containing
[3H]myristic acid (100 WCi/ml). For the treatment with staurosporine,
the cells were ¢rst incubated at 37‡C for 2 h in 1 ml of DMEM with
2% FCS containing [3H]myristic acid (100 WCi/ml). Staurosporine was
added to the medium at a ¢nal concentration of 2 WM, and then the
cells were further incubated at 37‡C for 4 h. Subsequently, the cells
were washed three times with Dulbecco’s phosphate-bu¡ered saline
(DPBS) and collected with cell scrapers, followed by lysis with 200
Wl of RIPA bu¡er [50 mM Tris^HCl (pH 7.5), 150 mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sul-
fate (SDS), proteinase inhibitors] on ice for 20 min. After immuno-
precipitation with anti-TNF or anti-FLAG antibody, the samples
were analyzed by SDS^PAGE (polyacrylamide gel electrophoresis)
and £uorography.
2.4. Western blotting
The total cell lysates of each group of transfected cells were ob-
tained at 48 h after transfection and resolved by 12.5% SDS^PAGE
and then transferred to an Immobilon-P transfer membrane (Milli-
pore). After blocking with non-fat milk, the membrane was probed
with a speci¢c anti-TNF or anti-FLAG antibody as described previ-
ously [14]. Immunoreactive proteins were speci¢cally detected by in-
cubation with horseradish peroxidase-conjugated Protein G (Bio-
Rad). The membrane was developed with enhanced chemilumines-
cence Western blotting reagent (Amersham) and exposed to X-ray
¢lm (Kodak).
2.5. Immunoprecipitation
Samples were immunoprecipitated with a speci¢c anti-TNF or anti-
FLAG antibody as described in [10].
2.6. SDS^PAGE and £uorography
Samples were denatured by boiling for 3 min in SDS-sample bu¡er
followed by analysis by SDS^PAGE on a 12.5% gel. Thereafter, the
gel was ¢xed and soaked in Amplify1 (Amersham) for 20 min. The
gel was dried under vacuum and exposed to X-ray ¢lm (Kodak) for
an appropriate period.
2.7. Immuno£uorescence analysis and £uorescence microscopy
Immuno£uorescence analysis of transfected cells was performed at
48 h after transfection. At this time point, the maximum level of
protein expression was achieved. For immunocytochemistry, cells
were washed with DPBS, ¢xed in 4% paraformaldehyde in DPBS
for 15 min, and permeabilized with 0.1% Triton X-100 in DPBS for
10 min at room temperature, followed by washing with 0.1% gelatin
in DPBS. The permeabilized cells were incubated with anti-FLAG
antibody (1:1000) in DPBS for 1 h at room temperature. After wash-
ing with 0.1% gelatin in DPBS, the cells were incubated with FITC-
conjugated anti-mouse IgG antibody for 1 h at room temperature.
Mitochondria were identi¢ed with 300 nM MitoTracker red, which
was incubated with the cells for 30 min before ¢xation. To observe
¢lamentous actin, the ¢xed and permeabilized cells were incubated
with 40 nM TRITC-conjugated phalloidin for 45 min at room temper-
ature. After washing with 0.1% gelatin in DPBS, the cells were ob-
served under a Zeiss Axiovert microscope.
3. Results
3.1. N-terminal sequence of the newly exposed N-terminus of
tActin and tGelsolin e⁄ciently directs protein
N-myristoylation
To determine whether the N-terminal sequence of the newly
exposed N-terminus of the truncated BID (tBID) could direct
cotranslational protein N-myristoylation, N-terminal nine res-
idues of the mature domain of TNF were replaced with those
of tBID to generate tBID-TNF (Fig. 1). In this case, the
initiating Met was inserted at the N-terminus of the fusion
protein. Then, its susceptibility to protein N-myristoylation
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was evaluated by in vivo metabolic labeling in transfected
cells.
When tBID-TNF was expressed in COS-1 cells, e⁄cient
expression of a protein with an expected molecular mass (17
kDa) was observed as determined by Western blotting using
anti-TNF antibody as shown in Fig. 2A, lane 1. Metabolic
labeling with [3H]myristic acid revealed an e⁄cient incorpo-
ration of [3H]myristic acid into tBID-TNF (Fig. 2B, lane 1).
To search for caspase substrates that would be posttransla-
tionally N-myristolyated upon caspase-mediated cleavage, the
susceptibility of the N-terminal sequence of the newly exposed
N-terminus of several caspase substrates to protein N-myris-
toylation was evaluated by in vivo metabolic labeling using
the strategy described above. In this case, six caspase sub-
strates (PARP, PKCj, p59FYN, actin, gelsolin, and MEKK-
1) that expose an N-terminal Gly upon cleavage were selected
as possible candidates. As shown in Fig. 2A, e⁄cient protein
expression was observed with tPARP-, tPKCj-, tp59FYN-,
tActin-, tGelsolin-, and tMEKK-1-TNF as with tBID-TNF,
as determined by Western blotting. [3H]myristic acid labeling
revealed that tActin- and tGelsolin-TNF were e⁄ciently
N-myristoylated as was tBID-TNF (Fig. 2B, lanes 5 and 6).
The e⁄ciency of [3H]myristic acid incorporation into tActin-
and tGelsolin-TNF was comparable to that into tBID-TNF.
Table 1
















Fig. 1. Schematic representation of the generation of tBID-TNF. The cDNA coding for tBID-TNF was generated from vpro-TNF cDNA by
site-directed mutagenesis. The N-terminal nine residues of the mature domain of TNF were replaced with those of tBID and the initiating Met
was introduced at the N-terminus to generate tBID-TNF.
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In contrast, no incorporation of [3H]myristic acid was ob-
served with tPARP-, tPKCj-, tp59FYN-, and tMEKK-1-
TNF despite the e⁄cient expression of these proteins.
3.2. In vivo expressed full-length tActin is e⁄ciently
N-myristoylated
As shown in Table 2, the N-terminal sequence of the newly
exposed N-terminus of tActin is highly conserved among var-
ious species, suggesting a critical role of the posttranslational
N-myristoylation of tActin in the physiology of cytoskeletal
actin. In contrast, the N-terminal sequence of the newly ex-
posed N-terminus of tGelsolin is not conserved. Since Pro at
the amino acid at position 3 has been shown to inhibit protein
N-myristoylation, it is quite probable that posttranslational
N-myristoylation will not occur on pig- and mouse-tGelsolin.
Therefore, we chose actin to further analyze the posttransla-
tional N-myristoylation of protein.
To con¢rm that the full-length tActin is N-myristoylated,
cDNAs coding for epitope-tagged actin and tActin were gen-
erated and their susceptibility to protein N-myristoylation was
evaluated by in vivo metabolic labeling. In this case, a FLAG-
tag was introduced at the C-terminus of these constructs. As
shown in Fig. 3A, lane 3, transfection of COS-1 cells with
cDNA coding for FLAG-tagged tActin gave rise to a 17
kDa protein band with an expected molecular mass (15 kDa
tActin plus 2 kDa linker and FLAG-tag). The 17 kDa protein
band was e⁄ciently N-myristoylated as determined by
[3H]myristic acid labeling (Fig. 3B, lane 3). When Gly2 of
tActin-FLAG was replaced with Ala (tActinG2A-FLAG),
[3H]myristic acid incorporation was completely inhibited, as
shown in Fig. 3A,B, lane 4. Interestingly, transfection of
FLAG-tagged actin gave rise to two protein bands; one is a
non-myristoylated major band with an expected molecular
mass (47 kDa: 45 kDa actin plus 2 kDa linker and FLAG-
tag) and the other is a fainter N-myristoylated 17 kDa protein
band (Fig. 3A,B, lane 1). These results indicated that actin
could be intracellularly cleaved to generate N-myristoylated
tActin.
3.3. Induction of apoptosis enhances the generation of
N-myristoylated tActin
To determine whether the intracellular generation of
N-myristoylated tActin is induced by caspase-mediated cleav-
age of actin during apoptosis, COS-1 cells transfected with
FLAG-tagged actin were treated with staurosporine, an in-
ducer of apoptosis, and the generation of N-myristoylated
tActin was determined by Western blotting and [3H]myristic
acid labeling. When COS-1 cells were treated with 2 WM stau-
rosporine, the cells died with the typical feature of apoptosis.
As shown in Fig. 4A,B, lanes 3 and 4, the amount of N-my-
ristoylated tActin was increased by the treatment with stau-
rosporine. This enhancement was signi¢cantly inhibited when
cells were pretreated with 100 WM of Z-VAD-fmk, a caspase
inhibitor, before addition of staurosporine (Fig. 4A,B, lane 5).
These results strongly indicated that the generation of N-my-
ristoylated tActin is induced by caspase-mediated cleavage of
actin during apoptosis.
Fig. 2. N-terminal sequence of the newly exposed N-terminus of
tActin and tGelsolin e⁄ciently directs protein N-myristoylation.
tBID-, tPARP-, tPKCj-, tp59FYN-, tActin-, tGelsolin-, and tMEKK-
1-TNF were expressed in COS-1 cells and the cells were labeled
with [3H]myristic acid. A: Total cell lysates were analyzed by West-
ern blotting using anti-TNF antibody. B: Following immunoprecipi-
tation with anti-TNF antibody, the labeled proteins were analyzed
by SDS^PAGE and £uorography.
Table 2
Comparison of the amino acid sequence around the caspase-cleav-
age site of actin and gelsolin derived from various species
Substrate Sequence
L-Actin human SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
pig SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
horse SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
mouse SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
rat SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
monkey SLEKSYELPD s G QVI
TIGNERFRCPEALFQP
Gelsolin human KNWRDPDQTD s G LGL
SYLSSHIANVERVPFD
pig KNWRDPDQVD s G PGL
SYLSSHIANVERVPFD
horse KNWRDPDQTE s G LGL
AYLSSHIAHVERVPFD
mouse KNWRDPDQTD s G PGL
GYLSSHIANVERVPFD
Caspase-cleavage sites are indicated by arrows. The N-terminal Gly
at the newly exposed N-terminus is represented in bold-face.
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3.4. Exogenously expressed tActin colocalized with
mitochondria without a¡ecting cellular and actin
morphology
When exogenously expressed in COS-1 cells, Actin-FLAG
colocalized with cellular ¢lamentous actin as determined by
the immuno£uorescence staining coupled with £uorescence
tagged-phalloidin staining as shown in the upper panels of
Fig. 5. In contrast, exogenously expressed tActin-FLAG did
not colocalize with ¢lamentous actin but showed clustered
localization within the cell without a¡ecting cellular and actin
morphology, as shown in the lower panels of Fig. 5.
Immuno£uorescence staining coupled with MitoTracker
staining revealed colocalization of tActin-FLAG with mito-
chondria, as shown in the upper panels of Fig. 6. The fact
that tActinG2A-FLAG showed di¡use cytosolic distribution
indicated that N-myristoylation of tActin promotes its target-
ing to mitochondria (lower panel of Fig. 6). As in the case of
tActin-FLAG expression, expression of tActinG2A-FLAG
did not a¡ect cellular and actin morphology (data not shown).
4. Discussion
Protein N-myristoylation has long been recognized as a
cotranslational protein modi¢cation. Recently, it was demon-
strated that N-myristoylation can also occur posttranslation-
ally, as in the case of pro-apoptotic protein BID [7]. This
post-proteolytic N-myristoylation of BID was found to pro-
mote its targeting to mitochondria as well as to enhance its
pro-apoptotic action in vivo. Since 16 of V60 identi¢ed cas-
pase substrates listed in a recent review [8] expose an N-ter-
minal Gly upon cleavage, it was suggested that the posttrans-
lational N-myristoylation might be a common modi¢cation in
apoptosis and perhaps other proteolytic pathways [7]. How-
ever, so far, BID is the only protein that has been proved to
be posttranslationally N-myristoylated upon caspase-mediated
cleavage. In the present study, we tried to search for caspase
substrates that are posttranslationally N-myristoylated upon
caspase-mediated cleavage. As it was demonstrated that
NMT, the enzyme responsible for cotranslational N-myristoy-
lation, could catalyze posttranslational N-myristoylation of
Fig. 3. tActin expressed in COS-1 cells is e⁄ciently N-myristoylated.
Actin-FLAG, tActin-FLAG and tActinG2A-FLAG were expressed
in COS-1 cells and the cells were labeled with [3H]myristic acid.
A: Total cell lysates were analyzed by Western blotting using anti-
FLAG antibody. B: Following immunoprecipitation with anti-
FLAG antibody, the labeled proteins were analyzed by SDS^PAGE
and £uorography.
Fig. 4. Induction of apoptosis enhances the generation of N-myris-
toylated tActin. COS-1 cells transfected with cDNA coding for Ac-
tin-FLAG were ¢rst incubated at 37‡C for 2 h in 1 ml of DMEM
with 2% FCS containing [3H]myristic acid (100 WCi/ml). Staurospo-
rine was added to the medium at a ¢nal concentration of 2 WM,
then the cells were further incubated at 37‡C for 4 h. For the treat-
ment of z-VAD-fmk, the cells were pretreated with 100 WM of
z-VAD-fmk for 2 h before addition of staurosporine. A: Total cell
lysates were analyzed by Western blotting using anti-FLAG anti-
body. B: Following immunoprecipitation with anti-FLAG antibody,
the labeled proteins were analyzed by SDS^PAGE and £uorogra-
phy.
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BID, it is quite probable that the enzyme responsible for
posttranslational N-myristoylation is NMT.
NMT has been puri¢ed and cloned from several organisms
[15^18]. The precise substrate speci¢city of this enzyme has
been characterized using puri¢ed enzyme and synthetic pep-
tide substrates [2,19,20]. In general, Ser or Thr is preferred at
position 6 and the N-terminal consensus motifs such as Met-
Gly-X-X-X-Ser/Thr-X-X [21] or Met-Gly-X-X-X-Ser/Thr-X-
X-X [5] that direct protein N-myristoylation have been de-
¢ned. However, Ser or Thr at position 6 is neither su⁄cient
Fig. 5. Exogenously expressed tActin did not a¡ect cellular or actin morphology. A,D: Subcellular localization of Actin-FLAG (panel A) and
tActin-FLAG (panel D) expressed in COS-1 cells was determined by immuno£uorescence staining using anti-FLAG antibody. B,E: Filamen-
tous actin in these cells was observed by TRITC-conjugated phalloidin staining. C,F: The merged image is shown.
Fig. 6. Colocalization of exogenously expressed tActin with mitochondria. A,D: Subcellular localization of tActin-FLAG (panel A) and tActin-
G2A-FLAG (panel D) expressed in COS-1 cells was determined by immuno£uorescence staining using anti-FLAG antibody. B: Mitochondria
in the same cell in panel A were identi¢ed by MitoTracker staining. C: The merged image is shown. Black and white image in panels A and B
shows the close-up (U4) view of the area surrounded by white box.
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nor critical for the recognition of the protein substrate by the
NMT. Some amino acid preferences were also reported at
other positions such as 3, 7 and 8 [2,22]. Recently, a sophis-
ticated program for automated prediction of protein N-my-
ristoylation from the substrate protein sequence has been de-
veloped and this prediction program is available as public
WWW-server [23,24]. When 16 caspase substrates having an
internal Gly residue that becomes an N-terminus after cleav-
age by caspase were investigated using this prediction pro-
gram, a ‘reliable’ myristoylation site was predicted only with
BID.
Previously, we have shown that the susceptibility of a pro-
tein to cotranslational N-myristoylation could easily be de-
tected by metabolic labeling in an in vitro or in vivo expres-
sion system using a fusion protein in which the N-terminal
sequence (V10 amino acid residues) of the query protein was
fused to a model protein [9]. With this experimental proce-
dure, we found that the amino acid residue penultimate to the
N-terminal Gly residue strongly a¡ects two cotranslational
protein modi¢cations, N-myristoylation and N-acetylation
[9]. In the present study, we utilized this strategy to detect
posttranslational N-myristoylation of caspase substrates.
As a result, it was found that the N-terminal nine residues
of the newly exposed N-terminus of the caspase-cleavage
products of cytoskeletal actin and gelsolin e⁄ciently direct
the protein N-myristoylation. In fact, when COS-1 cells tran-
siently transfected with cDNA coding for epitope-tagged full-
length actin were treated with staurosporine, an apoptosis-
inducing agent, an N-myristoylated tActin was generated, as
demonstrated by in vivo metabolic labeling with [3H]myristic
acid. Immuno£uorescence staining coupled with MitoTracker
or £uorescence tagged-phalloidin staining revealed that exo-
genously expressed tActin colocalized with mitochondria
without a¡ecting cellular and actin morphology.
Apoptosis accompanies a dramatic reorganization of the
cytoskeleton, which is followed by morphological changes
and cellular fragmentation. The involvement of the actin ¢la-
ment in the morphological changes of apoptosis has been
suggested by some inhibitor studies [25]. It was found that
actin is the substrate of caspases [26,27] and actin fragments
cleaved by caspase-1 could not polymerize e¡ectively in vitro
[28]. Recently, it was reported by Mashima et al. that, in some
tumor cells, induction of apoptosis was accompanied by cas-
pase-dependent actin-cleavage to 31 and 15 kDa fragments
[29]. It was also found that ectopic expression of the 15
kDa C-terminal fragment, but not the 31 kDa N-terminal
fragment, induced morphological changes resembling those
of apoptotic cells, while the 15 kDa fragment expression
caused neither caspase activation nor cleavage of a marker
substrate protein, PARP. Thus, generation of tActin seems
to play a positive role in the morphological changes of apo-
ptosis downstream of caspase activation. In the present study,
however, it was clearly demonstrated from £uorescence
tagged-phalloidin staining that exogenously expressed tActin
did not a¡ect cellular or actin morphology. These results form
a striking contrast to the results obtained by Mashima et al.
One possible explanation for the discrepancy might be the
di¡erence in the cell line used for the analysis. To test this
possibility, the same experiments reported in the present study
were performed using 293T cells used in the study by Mashi-
ma et al. and the obtained results were compared with those
of COS-1 cells. As a result, the same level of protein expres-
sion and [3H]myristic acid incorporation was observed when
tActin was expressed in these two cell lines (data not shown).
In addition, similar subcellular localization of tActin was ob-
served and no obvious changes in overall cell morphology or
the actin cytoskeleton were detected. Therefore, the di¡erence
in the cell line used for the study is not the reason for the
discrepancy. Thus, we could not obtain the experimental evi-
dence that explains the obvious discrepancy between our data
and those of Mashima et al.
Instead of a¡ecting actin structure, tActin was found to
colocalize with mitochondria. The fact that replacement of
Gly2 of tActin with Ala completely inhibited its localization
to mitochondria indicated that N-myristoylation of tActin
promotes its targeting to mitochondria. In the case of tBID,
N-myristoylation is directly involved in BID targeting to mi-
tochondria, its insertion into the outer membrane of mito-
chondria, the release of cytochrome c, and the killing of cells.
In contrast, tActin localized at mitochondria did not induce
cellular apoptosis. Further studies are required to reveal the
physiological roles of mitochondrial localization of tActin.
Another important issue to be clari¢ed is the mechanism for
mitochondrial targeting of tActin. Recent studies using GFP
chimeras containing N-myristoylation signal revealed that
N-myristoylated chimeric GFPs were localized to intracellular
membranes including endoplasmic reticulum and endosomes,
and were absent from mitochondria [30]. The fact that both
of the posttranslationally N-myristoylated proteins so far dis-
covered localized to mitochondria but not to other intracellu-
lar membranes might indicate that posttranslational protein
N-myristoylation functions as a novel form of mitochondrial
targeting signal. Further analyses are required to clarify the
molecular mechanisms for mitochondrial targeting of these
proteins.
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